Qumica Sinttica competitive analysis

Explore patent oppositions filed by Qumica Sinttica against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 9, 2026
Patent NumberTitleApplicantOpposition Date
Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-Benzoxazole For Use As A MedicamentPFIZEROct 29, 2024
Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-BenzoxazolePFIZERAug 3, 2022
(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofAMGEN EUROPEOct 15, 2019

Latest PTAB cases involving Qumica Sinttica

Discover the latest PTAB cases involving Qumica Sinttica, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Qumica Sinttica with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 9, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
QUMICA SINTTICA3 - - -
AMGEN EUROPE240 - -
CELGENE - 72 - 11
PFIZER54984412